Skip to content

Effectiveness analysis of navigation-guided visualization puncture technique in treating patients with cerebral hemorrhage

Analysis of the effect of navigation-guided visualization puncture technique in the treatment of patients with moderate spontaneous intracerebral hemorrhage with mild disturbance of consciousness: a prospective, randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400091827
Enrollment
Unknown
Registered
2024-11-04
Start date
2024-12-01
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Combined with mild disturbance of consciousness and moderate amount of spontaneous cerebral hemorrhage

Interventions

Non-visual minimally invasive treatment group:Minimally invasive evacuation of non-visualized cerebral hematoma
Navigation minimally invasive treatment group:Minimally Invasive Hematoma Removal Guided by Neuronavigation
Control group (conservative treatment group):None

Sponsors

Shenshan Medical Central, Memorial Hospital of Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Head CT scan confirmed the diagnosis of cerebral hemorrhage; 2. a definite history of hypertension; 3. The volume of supratentorial bleeding was 20-30 ml, and the GCS score was 12-14 at admission. 4. stable vital signs without cerebral hernia; 5. aged from 18 to 80 years old; 6. Ensure that none of the enrolled patients took anticoagulant drugs before operation.

Exclusion criteria

Exclusion criteria: 1. Unstable vital signs and moderate to severe coma; 2. patients with serious medical diseases (heart function, liver and kidney dysfunction) who could not tolerate surgery; 3. patients with cerebrovascular malformation or intracranial aneurysm detected by cerebrovascular examination; 4. patients with significantly abnormal coagulation function; 5. GCS less than 12 points, more than 14 points.

Design outcomes

Primary

MeasureTime frame
Hematoma clearance rate;Postoperative Complications;Prognosis of patients;

Secondary

MeasureTime frame
Glasgow Coma Scale;Length of stay;

Countries

China

Contacts

Public ContactWeng Yinlun

Shenshan Medical Central, Memorial Hospital of Sun Yat-sen University

wengyl5@mail.sysu.edu.cn+86 13672412805

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026